Ingrezza Sprinkle Capsules Received FDA Approval for Tardive Dyskinesia in Adults

The new formulation was approved to help patients with tardive dyskinesia who have trouble swallowing.

Related Keywords

Eiryw Roberts ,Mitchell Mathis ,Neurocrine Biosciences ,Division Of Psychiatry Products ,Drug Administration ,Ingrezza Sprinkle ,Chief Medical Officer ,Fast Track ,Priority Review ,Breakthrough Therapy ,Psychiatry Products ,Drug Evaluation ,